Biopsy

Negative effects on medical research

Lung biopsy

Renal biopsy

Prostate biopsy

[Comment] Sentinel node biopsy and neoadjuvant chemotherapy

Use of sentinel-lymph-node biopsy as standard care for axillary staging in patients with clinically node-negative (cN0) breast cancer is supported by scientific literature covering all aspects of the...

[Articles] Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

Sentinel-lymph-node biopsy is a reliable diagnostic method before neoadjuvant chemotherapy. After systemic treatment or early sentinel-lymph-node biopsy, the procedure has a lower detection rate and a...

Imaging After Negative Breast Biopsy Adds $$$ (CME/CE)

(MedPage Today) -- Routine interval breast imaging after a benign biopsy added substantially to the cost of care but provided minimal benefit, according to a retrospective chart review.

Prostate Biopsy Triggers Tx in Older Men (CME/CE)

(MedPage Today) -- Prostate cancer screening and biopsy declined as age increased, but most older men who underwent biopsy received aggressive treatment, a review of a large Veterans Affairs populatio...

Epigenetic Assay Identifies Biopsy-Negative Prostate Cancer

AUA 2012: A multiplexed epigenetic gene assay accurately identifies two thirds of prostate cancers with initial false-negative biopsies. Medscape Medical News

Study: Image-guided biopsy viable in prostate cancer

Image-guided targeted biopsy can be used to diagnose prostate cancer, potentially offering a more accurate approach than traditional blind biopsy, according to a recently published study.

Genetic test may reduce need for repeat biopsy for prostate cancer

Karim Kader, MD, PhD, associate clinical professor at the UC San Diego School of Medicine, together with a team of researchers from Wake Forest University School of Medicine, have developed a genetic...

Precision Biopsy names CEO, announces clinical-trial success

Colorado biotech company Precision Biopsy LLC said Monday that Amir Tehrani has been appointed its CEO. Tehrani previously was president and CEO of Amaranth Medical.   Precision Biopsy -- a unit...

Management of Rising Prostate-specific Antigen After a Negative Biopsy.

Prostate biopsy remains one of the most commonly performed urologic office procedures. A significant percentage of men with a negative result may have unrecognized disease. Inadequate biopsy strategie...

Diagnostic performance of initial transperineal 14-core prostate biopsy to detect significant cancer.

PURPOSE: To investigate cancers missed by extended transperineal (TP) 14-core biopsy (TP14PBx) and examined its diagnostic performance. METHODS: We evaluated 744 men with prostate-specific antigen (PS...

Subsequent risks for cervical precancer and cancer in women with low-grade squamous intraepithelial lesions unconfirmed by colposcopy-directed biopsy: results from a multicenter, prospective, cohort study.

OBJECTIVE: To investigate the natural course of low-grade squamous intraepithelial lesions (LSILs) that cannot be histologically confirmed by colposcopy-directed biopsy. METHODS: In a multicenter, pro...

MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy.

PURPOSE: To investigate the positive biopsy rate of MRI-guided biopsy (MR-GB) in a routine clinical setting, identify factors predictive for positive biopsy findings and to report about the clinical s...

Are Biopsy Specimens Predictive of HER2 Status in Gastric Cancer Patients?

BACKGROUND: Trastuzumab has been recently proposed as a treatment for patients with HER2-positive advanced/metastatic gastric cancer (GC). Since most patients have inoperable disease at diagnosis, acc...